Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. - Wikidata - awgldk - TriplyDB

Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.

Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.

http://www.wikidata.org/entity/Q35467763

about

A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor.Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.The intestinal uptake of particles and the implications for drug and antigen delivery Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.Past, present, and future technologies for oral delivery of therapeutic proteins.Recent trends in vaccine delivery systems: A review.

P2860

Q33752525-C6E0A057-7BBB-4629-90B8-C1F6680580AE Q33785598-806B560E-4354-4DF4-8D28-E18DA8416380 Q33882052-C49AA3BA-3161-4FFE-A7F7-161C20602EE7 Q34000504-59E5D1D6-EEEF-482C-B326-54B1B8809349 Q34002672-A2BCB7E4-7257-431B-87C6-5510CF462C17 Q36232650-3151F728-0F9B-495E-9F2C-14CADB6B0B96 Q36300181-D88A6F67-EEDD-4475-BE72-9736DFBD6BA1

P2860

Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.

http://www.wikidata.org/entity/Q35467763

description

1996 nî lūn-bûn

@nan

1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Orally administered microencap ...... rtussis respiratory infection.

@ast

Orally administered microencap ...... rtussis respiratory infection.

@en

type

label

Orally administered microencap ...... rtussis respiratory infection.

@ast

Orally administered microencap ...... rtussis respiratory infection.

@en

prefLabel

Orally administered microencap ...... rtussis respiratory infection.

@ast

Orally administered microencap ...... rtussis respiratory infection.

@en

P1433

Q35467763-E2D2E635-F743-4CA7-A827-D88C65104BF7

P1476

Q35467763-446B989D-208D-474F-8633-D8074EA2C5C0

P2093

Q35467763-04C00EA2-C3AA-426E-930A-4861CF20F786

Q35467763-09AE08AF-9CEC-4A4F-A77D-425D8203084B

Q35467763-47E57B43-684E-40A1-BE31-5F74F44AC605

Q35467763-7B163FD2-48D6-43E7-8C42-395CE8C88FCC

Q35467763-BE057A78-4C35-48BD-B793-E34185854CCF

Q35467763-CE2A526B-3D98-4B9D-B6B0-87B97883D022

P2860

Q35467763-0B180ACC-D236-4A5D-A6EC-D33F89CA3419

Q35467763-196194EA-0825-4A10-B2DD-BEC7AA1D9429

Q35467763-2390697C-8D7B-40F9-AEFD-11988F07ABD2

Q35467763-23B57D41-3ECE-4573-88D4-354F598AEF9C

Q35467763-2A9A593F-9E79-41E1-870B-487184F88076

Q35467763-34535E77-BAB5-4944-AA1C-5892006C70D6

Q35467763-396855CA-0A84-4C52-AA4F-60FE61916E6A

Q35467763-412C6147-E61B-4A5B-A996-1A3BFFA5081F

Q35467763-4B4D56A0-C533-49AE-B9B9-B6FC32690D9B

Q35467763-4B6B9DAE-7E02-4B52-B4F3-298D6CB89293

P304

Q35467763-27C434F0-4344-4E1A-8B0B-56ED76F6B973

P31

Q35467763-75DC4B35-9FD4-417F-B367-5E867E50420C

P407

Q35467763-02542213-644A-4AFE-8296-B2DC72B790A6

P433

Q35467763-637CB000-CA2E-4F7B-A2C2-6E76FDEF1727

P478

Q35467763-DF540B5D-A055-43DE-8857-6DCA912CABD0

P577

Q35467763-3593515F-FAF3-4B23-9563-B1561466089E

P698

Q35467763-50A4AF22-AFDA-4071-A4E7-1AF5B053F1C1

P921

Q35467763-49517340-C092-4742-8E7B-0E398410CB5C

P932

Q35467763-44EC6218-C53B-43AA-8D10-DDDF7A71D5BF

P1433

Infection and Immunity

P1476

Orally administered microencap ...... rtussis respiratory infection.

@en

P2093

Farrar GH

http://www.w3.org/2001/XMLSchema#string

Jones DH

http://www.w3.org/2001/XMLSchema#string

McBride BW

http://www.w3.org/2001/XMLSchema#string

O'Hagan DT

http://www.w3.org/2001/XMLSchema#string

Robinson A

http://www.w3.org/2001/XMLSchema#string

Thornton C

http://www.w3.org/2001/XMLSchema#string

P2860

Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.

Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres

Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization.

Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces.

Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.

Structural specializations for antigen uptake and processing in the digestive tract.

Protection against vaginal SIV transmission with microencapsulated vaccine.

Biodegradable microparticles for oral immunization.

P304

489-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

1996-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8550197

http://www.w3.org/2001/XMLSchema#string

P921

Bordetella pertussis

P932

173791

http://www.w3.org/2001/XMLSchema#string